文献速递肝肾功能剂量调整药物不良反应与药物警戒

痴呆患者药物不良反应相关住院的预测因素:回顾性病例对照研究

Predictors of Adverse Drug Reaction-Related Hospitalisations Among People with Dementia: A Retrospective Case-Control Study.
PubMed 文献 · Drug Saf · 2024-05-13

该回顾性病例对照研究分析澳大利亚塔斯马尼亚2010年7月至2021年7月≥65岁痴呆住院患者,发现23.7%至少发生一次药物不良反应相关住院。肾损伤最常见(36.0%),利尿剂、RAS抑制剂和抗血栓药为主要涉事药物,慢性肾病、澳大利亚出生、高血压和用药数量是预测因素。

要点

  • 痴呆患者中23.7%至少发生一次药物不良反应相关住院。
  • 肾损伤(急性肾损伤)最常见,占36.0%。
  • 慢性肾病、高血压和用药数量是预测因素。

核心结论

  • 慢性肾病、澳大利亚出生、高血压和用药数量可预测痴呆患者药物不良反应相关住院,有助于识别高风险个体并设计针对性干预。

研究设计与样本

  • 回顾性病例对照研究,分析2010年7月至2021年7月澳大利亚塔斯马尼亚主要公立医院≥65岁痴呆住院患者病历。
  • 研究期间7928例至少住院一次,其中1876例(23.7%)经历至少一次药物不良反应相关住院。
  • 随机选取300例病例患者(共311次药物不良反应)和300例对照患者。

主要发现

  • 最常见药物不良反应类型为肾损伤(急性肾损伤),占36.0%。
  • 其他类型包括神经精神(17.6%)、心血管(16.0%)和血液学(13.1%)。
  • 主要涉事药物类别为利尿剂、肾素-血管紧张素系统抑制剂和抗血栓药。
  • 药物不良反应相关住院与慢性肾病(OR 8.00,95% CI 2.63-24.28,p < 0.001)、澳大利亚出生(OR 1.62,95% CI 1.08-2.43,p = 0.019)、高血压(OR 1.48,95% CI 1.01-2.17,p = 0.044)和用药数量(OR 1.06,95% CI 1.00-1.12,p = 0.022)相关。
  • 潜在不适当用药和抗胆碱能负荷未预测药物不良反应相关住院。

临床怎么用

  • 对痴呆患者应重点关注慢性肾病、高血压、多重用药及澳大利亚出生人群,以识别药物不良反应相关住院高风险个体。
  • 处方利尿剂、RAS抑制剂和抗血栓药时需加强监测,尤其关注肾损伤风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Adverse drug reactions (ADRs) are common among people with dementia; however, little is known about the magnitude and predictors associated with ADR-related hospitalisation among these individuals. This study aimed to determine the magnitude, types, drugs implicated and predictors of ADRs associated with hospitalisation among people with dementia. METHODS: This retrospective case-control study analysed medical records of individuals aged ≥ 65 years with dementia admitted to major public hospitals in Tasmania, Australia, from July 2010 to July 2021. Adverse drug reactions and implicated drugs were identified using administrative data and cross-checked with hospital medical records, with consensus reached among the research team. RESULTS: Of the 7928 people admitted to hospital at least once within the study period, 1876 (23.7%) experienced at least one ADR-related hospitalisation. Of these, 300 case patients with 311 ADRs and 300 control patients were randomly selected. The most common types of ADRs were renal (acute kidney injury; AKI) (36.0%), followed by neuropsychiatric (17.6%), cardiovascular (16.0%) and haematological (13.1%). Diuretics, renin-angiotensin system (RAS) inhibitors and anti-thrombotics constituted the main implicated drug classes. The ADR-related hospitalisation was associated with: chronic kidney disease (CKD) (OR 8.00, 95% CI 2.63-24.28, p < 0.001), Australian-born (OR 1.62, 95% CI 1.08-2.43, p = 0.019), hypertension (OR 1.48, 95% CI 1.01-2.17, p = 0.044) and the number of medicines (OR 1.06, 95% CI 1.00-1.12, p = 0.022). Potentially inappropriate medication use and anticholinergic burden did not predict ADR-related hospitalisation. CONCLUSIONS: These predictors could help identify the individuals at the highest risk and enable targeted interventions to be designed.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Zaidi AS, Peterson GM, Curtain CM, et al. Predictors of Adverse Drug Reaction-Related Hospitalisations Among People with Dementia: A Retrospective Case-Control Study. Drug Saf. 2024. PMID: 38739234. doi:10.1007/s40264-024-01435-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。